Clinical molecular subtyping study based on precision Fusobacterium detection in colrectal cancer.

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036197

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Tumor tissue group and tumor-adjacent tissue group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years; 2. Clinically diagnosed as colorectal cancer; 3. Willing to cooperate in sample collection.

Exclusion criteria

Exclusion criteria: 1. Sever diseases in heart, liver, kidney or other organs; 2. Pregnant or lactating women; 3. The patient were also accompanied with multiple organ tumors or severe uncontrolled medical disease or acute infection; 4. Patients don't understand the purpose of this study or dont agree with requirements for the study; 5. Patients who lack of legal capacity or limitation of legal capacity; 6. Patients who have related medical history which could interfere results and increase risk of patients.

Design outcomes

Primary

Measure	Time frame
Identification of clostridium species;	—

Countries

China

Contacts

Public ContactQing Wei

Shanghai Tenth People's Hospital

weiqing1971@aliyun.com+86 18917689343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026